Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.
about
Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin ActivatorsA Lupus-Associated Mac-1 Variant Has Defects in Integrin Allostery and Interaction with Ligands under ForceMicroglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity.A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy.Leukadherin-1 ameliorates endothelial barrier damage mediated by neutrophils from critically ill patients.
P2860
Q35036412-7D2C3297-140B-486B-B18E-D715C58264C8Q36549097-3656540B-9684-44AC-AF98-3A7485354295Q37730623-5C06662E-7513-4EE5-ACEC-E28280A294B9Q38160780-456DF47B-5451-414F-B021-BB82DCB27C17Q39415173-7D9E9FDE-1E02-461E-97C3-1445DBDDE8D5Q42191523-3D4F8BA1-7378-4AE0-99AB-9060A8475297Q42292861-1B2AD783-A741-42A8-B6C9-69B64C4AC990Q43103019-C7BF1198-1183-4E46-AA24-216CE46A1910Q52641478-0F1E7FAD-CB5C-4462-B5A1-E2DF823BFC56
P2860
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Small molecule agonists of int ...... s in reducing vascular injury.
@ast
Small molecule agonists of int ...... s in reducing vascular injury.
@en
type
label
Small molecule agonists of int ...... s in reducing vascular injury.
@ast
Small molecule agonists of int ...... s in reducing vascular injury.
@en
prefLabel
Small molecule agonists of int ...... s in reducing vascular injury.
@ast
Small molecule agonists of int ...... s in reducing vascular injury.
@en
P2093
P2860
P1476
Small molecule agonists of int ...... s in reducing vascular injury.
@en
P2093
Camilo Gomez
Juan Camilo Duque
Mohd Hafeez Faridi
Roberto I Vazquez-Padron
P2860
P304
P356
10.1016/J.BBAGEN.2013.02.018
P407
P577
2013-02-26T00:00:00Z